BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18389784)

  • 1. [The impact of patient and tumor related prognostic factors on survival in non-medullary differentiated thyroid cancer. A study of 125 cases].
    Dănilă R; Popovici R; Grigorovici A; Ionescu L; Timofte D; Lefter L; Boiculesei LV; Ungureanu MC; Dragomir C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):940-5. PubMed ID: 18389784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in well-differentiated thyroid carcinoma.
    Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of differentiated thyroid carcinoma: a retrospective study.
    De Falco M; Oliva G; Ragusa M; Misso C; Parmeggiani D; Sperlongano P; Calzolari F; Puxeddu E; Misso C; Marzano LA; Barbarisi A; Parmeggiani U; Avenia N
    G Chir; 2008 Apr; 29(4):152-8. PubMed ID: 18419979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
    Verburg FA; Mäder U; Luster M; Reiners C
    Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors determining survival in patients with node positive differentiated thyroid cancer: a retrospective cross-sectional study.
    Gulcelik MA; Ozdemir Y; Kadri Colakoglu M; Camlibel M; Alagol H
    Clin Otolaryngol; 2012 Dec; 37(6):460-7. PubMed ID: 22971040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deaths due to differentiated thyroid cancer: a South Island, New Zealand experience: 1984-2009.
    Brownlie BJ; Turner J; Abdelaal AS
    N Z Med J; 2012 Oct; 125(1363):13-21. PubMed ID: 23159897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
    Machens A; Hauptmann S; Dralle H
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan expression in differentiated thyroid carcinoma.
    Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
    J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
    Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.